• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴雷特食管中流式细胞术异常与发育异常之间的不一致。

Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus.

作者信息

Fennerty M B, Sampliner R E, Way D, Riddell R, Steinbronn K, Garewal H S

机构信息

Veterans Administration Medical Center, Hamilton, Ontario, Canada.

出版信息

Gastroenterology. 1989 Oct;97(4):815-20. doi: 10.1016/0016-5085(89)91483-2.

DOI:10.1016/0016-5085(89)91483-2
PMID:2777038
Abstract

Eighty-six specimens from 25 patients with Barrett's epithelium were analyzed by both histology and flow cytometry. Of these, 73 were without dysplasia and 13 had dysplasia (7 low grade, 6 high grade). Eight of the nondysplastic specimens were aneuploid and another 15 had increased G2. Among the dysplastic specimens, two were aneuploid and two had increased G2. These data were grouped into four classifications: type 1 (65 specimens), specialized columnar epithelium (Barrett's) without dysplasia and no aneuploidy; type 2 (8 specimens), Barrett's epithelium without dysplasia and an aneuploid cell population; type 3 (11 specimens), Barrett's epithelium with dysplasia and no aneuploidy; and type 4 (2 specimens), Barrett's epithelium with dysplasia and aneuploidy. Distribution by type was 76%, 9%, 13%, and 2%, respectively. We conclude that histologic dysplasia and aneuploidy are often discordant. They may identify separate subgroups at risk, or when concordant, may reflect an increased cancer risk in that population. Further study will define the role of histology and flow cytometry in the screening and management of patients with Barrett's esophagus.

摘要

对25例患有巴雷特上皮的患者的86份标本进行了组织学和流式细胞术分析。其中,73份无发育异常,13份有发育异常(7份低级别,6份高级别)。8份无发育异常的标本为非整倍体,另外15份G2期增加。在发育异常的标本中,2份为非整倍体,2份G2期增加。这些数据被分为四类:1型(65份标本),无发育异常且无非整倍体的特殊柱状上皮(巴雷特上皮);2型(8份标本),无发育异常但有非整倍体细胞群的巴雷特上皮;3型(11份标本),有发育异常但无非整倍体的巴雷特上皮;4型(2份标本),有发育异常且有非整倍体的巴雷特上皮。各类型的分布分别为76%、9%、13%和2%。我们得出结论,组织学上的发育异常和非整倍体常常不一致。它们可能识别出不同的高危亚组,或者当二者一致时,可能反映出该人群患癌风险增加。进一步的研究将明确组织学和流式细胞术在巴雷特食管患者筛查和管理中的作用。

相似文献

1
Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus.巴雷特食管中流式细胞术异常与发育异常之间的不一致。
Gastroenterology. 1989 Oct;97(4):815-20. doi: 10.1016/0016-5085(89)91483-2.
2
Correlation of ultrastructural aberrations with dysplasia and flow cytometric abnormalities in Barrett's epithelium.巴雷特食管上皮超微结构异常与发育异常及流式细胞术异常的相关性
Gastroenterology. 1989 Feb;96(2 Pt 1):355-67. doi: 10.1016/s0016-5085(89)91559-x.
3
Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort.巴雷特食管向恶性肿瘤的流式细胞术和组织学进展:队列的前瞻性内镜监测
Gastroenterology. 1992 Apr;102(4 Pt 1):1212-9.
4
Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma.巴雷特食管。流式细胞术与组织学在检测腺癌高危患者中的相关性。
Gastroenterology. 1987 Jul;93(1):1-11.
5
Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study.发育异常和非发育异常的巴雷特食管的亚甲蓝染色:一项体内和体外研究。
Endoscopy. 2001 May;33(5):391-400. doi: 10.1055/s-2001-14427.
6
Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry.通过双参数流式细胞术评估巴雷特食管中p53蛋白的表达。
Gastroenterology. 1992 Apr;102(4 Pt 1):1220-8.
7
[Flow cytometric analysis of cellular DNA content in Barret's esophagus. A study of 66 cases].[巴雷特食管细胞DNA含量的流式细胞术分析。66例研究]
Gastroenterol Clin Biol. 1991;15(10):703-10.
8
Barrett's esophagus. Correlation between mucin histochemistry, flow cytometry, and histologic diagnosis for predicting increased cancer risk.巴雷特食管。黏蛋白组织化学、流式细胞术与组织学诊断之间的相关性,用于预测癌症风险增加。
Am J Pathol. 1988 Apr;131(1):53-61.
9
Cyclooxygenase-2 expression in esophageal epithelium before and after photodynamic therapy for Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.光动力疗法治疗伴高级别异型增生或黏膜内癌的 Barrett 食管前后食管上皮中环氧化酶-2 的表达。
Virchows Arch. 2011 Dec;459(6):581-6. doi: 10.1007/s00428-011-1167-x. Epub 2011 Nov 13.
10
Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus.Ki-67增殖区的扩大与巴雷特食管的发育异常程度相关。
Cancer. 1995 Jan 15;75(2):423-9. doi: 10.1002/1097-0142(19950115)75:2<423::aid-cncr2820750202>3.0.co;2-5.

引用本文的文献

1
Genetic Insights in Barrett's Esophagus and Esophageal Adenocarcinoma.巴雷特食管和食管腺癌的遗传学见解
Gastroenterology. 2015 Oct;149(5):1142-1152.e3. doi: 10.1053/j.gastro.2015.07.010. Epub 2015 Jul 21.
2
Medical and endoscopic management of high-grade dysplasia in Barrett's esophagus.巴雷特食管高级别异型增生的医学和内镜处理。
Dis Esophagus. 2012 May;25(4):349-55. doi: 10.1111/j.1442-2050.2012.01342.x. Epub 2012 Mar 12.
3
Early events during neoplastic progression in Barrett's esophagus.巴雷特食管癌变过程中的早期事件。
Cancer Biomark. 2010;9(1-6):307-24. doi: 10.3233/CBM-2011-0162.
4
Open questions in oesophageal adenocarcinogenesis.食管腺癌发生过程中的开放性问题。
Gut. 2007 Jul;56(7):897-8. doi: 10.1136/gut.2006.117135.
5
NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.非甾体抗炎药可调节CDKN2A、TP53以及进展为食管腺癌的DNA含量风险。
PLoS Med. 2007 Feb;4(2):e67. doi: 10.1371/journal.pmed.0040067.
6
Drinking from the fountain of promise: biomarkers in the surveillance of Barrett's oesophagus--the glass is half full!从希望之泉汲取:巴雷特食管监测中的生物标志物——杯子还有半杯!
Gut. 2006 Oct;55(10):1377-9. doi: 10.1136/gut.2006.096461.
7
Barrett's oesophagus: from metaplasia to dysplasia and cancer.巴雷特食管:从化生到发育异常再到癌症
Gut. 2005 Mar;54 Suppl 1(Suppl 1):i6-12. doi: 10.1136/gut.2004.041525.
8
Barrett's esophagus: model of neoplastic progression.巴雷特食管:肿瘤进展模型
World J Surg. 2003 Sep;27(9):1009-13. doi: 10.1007/s00268-003-7053-1. Epub 2003 Aug 18.
9
Molecular biology of Barrett's adenocarcinoma.巴雷特腺癌的分子生物学
Ann Surg. 2001 Mar;233(3):322-37. doi: 10.1097/00000658-200103000-00005.
10
Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets.巴雷特食管进展为癌症的预测因素:基线组织学和流式细胞术可识别低风险和高风险患者亚组。
Am J Gastroenterol. 2000 Jul;95(7):1669-76. doi: 10.1111/j.1572-0241.2000.02196.x.